Small-cell lung cancer is characterized by a high incidence of deletions on chromosomes 3p, 4q, 5q, 10q, 13q and 17p

British Journal of Cancer

Volumn 75, Issue 1, 1997, Pages 79-86

  Petersen, I ^a   Langreck, H ^a   Wolf, G ^a   Schwendel, A ^a   Psille, R ^a   Vogt, P ^b   Reichel, M B ^b   Ried, T ^c   Dietel, M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

Author keywords

Comparative genomic hybridization; Loss of heterozygosity; Lung cancer; Small cell lung cancer; Tumour genetics

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GENETICS; CHROMOSOME 10Q; CHROMOSOME 13Q; CHROMOSOME 15Q; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 3P; CHROMOSOME 4Q; CHROMOSOME 5Q; CLINICAL ARTICLE; FEMALE; GENE DELETION; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LUNG SMALL CELL CANCER; MALE; PRIORITY JOURNAL;

EID: 0031012404     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.13     Document Type: Article

References (64)

1. Brennan J, O'Conner T, Makuch RW, Simmons AM, Russell E, Linnoila RI, Gazdar AF, Ihde DC and Johnson BE (1991) myc family DNA amplification in 107 tumours and tumour cell lines from patients with small cell lung cancer treated with different combination of chemotherapy regimens. Cancer Res 51: 1708-1721
2. Brison O (1993) Gene amplification and tumour progression. Biochem Biophys Acta 1155: 25-11
3. Brzoska PM, Levin NA, FU KK, Kaplan MJ, Singer MI, Gray JW and Christman MF (1995) Frequent novel DNA copy number increase in squamous cell head and neck tumours. Cancer Res 55: 3055-3059
4. Buetow KH, Murray JC, Israel JL, London WT, Smith M, Kew M, Blanquet V, Brechot C, Redeker A and Govindarajah S (1989) Loss of heterozygosity suggests tumour suppressor gene responsible for primary hepatocellular carcinoma. Proc Natl Acad Sci USA 86: 8852-8856
5. Cottrell S and Bodmer WF (1942) Two Mspl polymorphisms within the APC gene. Hum Mol Genet 1: 352
6. Eagle LR, Yin X, Brothman AR, Williams BJ, Atkin NB and Prochownik EV (1995) Mutation of the MXII gene in prostate cancer. Nature Genet 9: 249-255
7. EL Torky M, EL Zeky F and Hall JC (1990) Significant changes in the distribution of histologic types of lung cancer. Cancer 65: 2361-2367
8. Field JK, Spandidos DA, Steel PM, Vaughan ED, Evan GI and Moore JP (1989) Elevated expression of the c-myc oncoprotein correlates with pour prognosis in head and neck squamous cell carcinoma. Oncogene 4: 1463-1468
9. Fox W and Scadding JG (1973) Medical Research Council comparative trial of surgery and radiotherapy for primary treatment of small-celled or oat-celled carcinoma of the bronchus: ten-year follow-up. Lancet 2: 63-65
10. Ganly PS and Rabbits PH (1992a) Polymerase chain reaction (PCR) for detection of Mspl polymorphism at the D3S30 locus. Nucleic Acids Res 19: 3757
11. Ganly PS and Rabbits PH (1992b) Polymerase chain reaction (PCR) for detection of BamHl polymorphism at the THRB gene. Nucleic Acids Res 19: 3757
12. Hibi K, Takahashi T, Yamakawa K, Ueda R, Sekido Y, Ariyoshi Y, Suyama M, Takagi H, Nakamura Y and Takahashi T (1992) Three distinct regions involved in 3p deletion in human lung cancer. Oncogene 7: 445-449
13. Hosoe S, Ueno K, Shigedo Y, Tachibana I, Osaki T, Kumagai T, Tanio Y, Kawase I, Nakamura Y and Kishimoto T (1994) A frequent deletion of chromosome 5q21 in advanced small cell and non-small cell carcinoma of the lung. Cancer Res 54: 1787-1790
14. Isola JJ, Kallioniemi OP, Chu LW, Fuqua Saw, Hilsenbeck SG, Osborne CK and Waldman FM (1995) Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer. Am J Pathol 147: 905-911
15. Isshiki K, Elder DE, Guerry D and Linnenbach AJ (1993) Chromosome 10 allelic loss in malignant melanoma. Genes Chrom Cancer 8: 178-184
16. Johnson RE, Brerton HD and Kent CH (1978) 'Total' therapy for small cell carcinoma of the lung. Ann Thorac Surg 25: 509-515
17. Kallioniemi OP, Kallioniemi A, Sudar D, Rutovitz D, Gray JW, Waldman F and Pinkel D (1992) Comparative genomic hybridization for molecular cytogenetic analysis of solid tumours. Science 258: 818-821
18. Kallioniemi OP, Kallioniemi A, Piper J, Isola J, Waldman KM, Gray JW and Pinkel D (1994) Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumours. Genes Chrom Cancer 10: 231-243
19. Kelley MJ, Nakagawa K, Steinberg SM, Mulshine JL, Kamb A and Johnson BE (1995) Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines. J Natl Cancer Inst 87: 756-761
20. Koorey DJ, Mccaughan GW, Trent RJ and Gallagher ND (1992) Dinucleotide repeat polymorphism at the D5S134 locus linked to the adenomatous polyposis coli (APC) gene. Hum Mol Genet 1: 655
21. Leenstra S, Bijlsma EK, Troost D, Oosting J, Westerveld A, Bosch DA and Hulsebos TJ (1994) Allele loss on chromosomes 10 and 17p and epidermal growth factor receptor gene amplification in human malignant astrocytoma related to prognosis. Br J Cancer 70: 684-689
22. Levin NA, Brzoska P, Gupta N, Minna JD, Gray JW and Christman MF (1994) Identification of frequent novel genetic alterations in small cell lung carcinoma. Cancer Res 54: 5086-5091
23. Li X, Lee NK, Ye YW, Waber PG, Schweitzer C, Cheng QC and Nisen PD (1994) Allelic loss at chromosomes 3p, 8p, 13p, and 17p associated with poor prognosis in head and neck cancer. J Natl Cancer Inst 86: 1524-1529
24. Medical Research Council Lung Cancer Working Party (1979) Radiotherapy alone or with chemotherapy in the treatment of small-cell carcinoma of the lung. Br J Cancer 40: 1-10
25. Miura I, Graziano SL, Cheng JQ, Doyle A and Testa JR (1992) Chromosome alterations in human small cell lung cancer: frequent involvement of 5q. Cancer Res 52: 1322-1328
26. Miyoshi Y, Nagase H, Ando H, Horii A, Shigetoshi I, Nakatsuru S, Aoki T, Miki Y, Mori T and Nakamura Y (1992) Somatic mutations of the APC gene in colorectal tumours: mutation cluster region in the APC gene. Hum Mol Genel 1: 229-233
27. Moch H, Presti JC, Sauter G, Buchholz N, Jordan P, Mihatsch MJ and Waldman FM (1996) Genetic aberrations detected by comparative genomic hybridization are associated with clinical outcome in renal cell carcinoma. Cancer Res 56: 27-30
28. Mori N, Yokota J, Oshima M, Cavanee WK, Mizoguchi H, Noguchi M, Shimosato Y, Sugimura T and Terada M (1989) Concordant deletions of chromosome 3p and loss of heterozygosity for chromosomes 13 and 17 in small cell lung carcinoma. Cancer Res 49: 5130-5135
29. Nimmo ER, Sanders PG, Padua RA, Hughes D, Williamson R and Johnson KJ (1991) The MEL gene: A new member of the RAB/YPT class of RAS-related genes. Oncogene 6: 1347-1351
30. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, Palazzo J, Siprashvili Z, Mori M, McCue P, Druck T, Croce CM and Huebner K (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t(3:8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587-597
31. Peiffer SL, Herzog TJ, Tribune DJ, Mutch DG, Gersell DJ and Goodfellow PJ (1995) Allelic loss of sequences from the long arm of chromosome 10 and replication errors in endometrial cancers. Cancer Res 55: 1922-1926
32. Petersen I, Reichel M, Vogl P and Dietel M (1993) PCR-based RFLP-analysis for the detection of loss of heterozygosity on chromosomes 3p and 5q in human lung carcinomas. J Cancer Res Clin Oncol 119: 60
33. Petersen I, Reichel MB and Dietel M (1996) Use of non-radioactive detection in SSCP, direct DNA sequencing and LOH analysis. J Clin Pathol (Mol Pathol) 49: M118-M121
34. Polascik TJ, Cairns P, Chang WY, Schoenberg MP and Sidransky D (1995) Distinct regions of allelic loss on chromosome 4 in human primary bladder carcinoma. Cancer Res 55: 5396-5399
35. Reifenberger G, Reifenberger J, Ichimura K and Collins VP (1995) Amplification at 12q13-14 in human malignant gliomas is frequently accompanied by loss of heterozygosity at loci proximal and distal to the amplification site. Cancer Res 55: 731-734
36. Rempel SA, Schwechheimer K, Davis RL, Cavanee WK and Rosenblum ML (1993) Loss of heterozygosity for loci on chromosome 10 is associated with morphologically malignant meningioma progression. Cancer Res 53: 2386-2392
37. Ried T, Baldini A, Rand TC and Ward TC (1992) Simultaneous visualization of seven different DNA probes by in situ hybridization using combinatorial fluorescence and digital imaging microscopy. Proc Natl Acad Sci USA 89: 1388-1392
38. Ried T, Petersen I, Holtgreve-Grez H, Speicher MR, Schröck E, DU Manoir S and Cremer T (1994) Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res 54: 1801-1806
39. Ries Lag, Hankey BF and Miller BA (1991) Cancer Statistics Review, 1973-1988. NIH publication 91-2789, National Cancer Institute: Bethesda, MD, USA.
40. Rodriguez E, Sreekantaiah C and Chaganti RSK (1994) Genetic changes in epithelial solid neoplasia. Cancer Res 54: 3398-3406
41. Roth K, Hufnagl P and Wolf G (1992) AMBA/D - a new programming environment for image processing. SPIE 1659: 254-261
42. Roth K, Wolf G, Dietel M and Petersen I (1996) Image analysis for comparative genomic hybridization (CGH) by a Windows-based karyotyping program. Anal Quant Cytol Histol. (manuscript submitted).
43. Sakurai A, Bell GI and Degroot LJ (1992) Dinucleotide repeat polymorphism in the human thyroid hormone receptor β gene (THRB) on chromosome 3. Nucleic Acids Res 19: 6661
44. Sameshima Y, Matsuno Y, Hirohashi S, Shimosato Y, Mizoguchi H, Sugimura T, Terada M and Yokota J (1992) Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene 7: 451-457
45. Sato S, Nakamura Y and Tsuchiya E (1994) Difference of allelotype between squamous cell carcinoma and adenocarcinoma of the lung. Cancer Res 54: 5652-5655
46. Schreiber-Agus N, Chin L, Chen K, Torres R, Rao G, Guida P, Skoultchi AI and Depinho RA (1995) An amino-terminal domain of the Mxi I mediates anti-myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3. Cell 80: 777-786
47. Sekido Y, Takahashi T, Ueda R, Takahashi M, Suzuki H, Nishida K, Tsukamoto T, Hida T, Shimokata K, Zsebo KM and Takahashi T (1993) Recombinant human stem cell factor mediates chemotaxis of small-cell lung cancer cell lines aberrantly expressing the c-kit protooncogene. Cancer Res 53: 1709-1714
48. Sekido Y, Bader S, Latif F Gnarra JR, Gazdar AF, Linehan WM, Zbar B, Lerman MI and Minna JD (1994) Molecular analysis of the von Nippel-Lindau disease tumour suppressor gene in human lung cancer cell lines. Oncogene 9: 1599-1604
49. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, Inoue H, Tornielli S, Pilotti S, De Gregorio L, Pastorino U, Pierotti MA, Ohta M, Huebner K and Croce CM (1996) The FIHT gene at 3p14.2 is abnormal in lung cancer. Cell 85: 17-26
50. Speicher MR, Howe C, Crotty P, Du Manoir S, Costa J and Ward DC (1995) Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 55: 1010-1013
51. Takahashi T, Obata Y, Sekido Y, Hida T, Ueda R, Watanabe H, Ariyoshi Y, Sugiura T and Takahashi T (1989) Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. Cancer Res 49: 2683-2688
52. Tsuchiya E, Nakamura Y, Weng S-Y, Nakagawa K, Tsuchiya S, Sugano H and Kitagawa T (1992) Allelotype of non-small cell lung carcinoma - comparison between loss of heterozygosity in squamous cell carcinoma and adenocarcinoma. Cancer Res 52: 2478-2481
53. Urano Y, Watanabe K, Lin CC, Hino O and Tamaoki T (1991) Interstitial chromosomal deletion within 4q11-q13 in a human hepatoma cell line. Cancer Res 51: 1460-1464
54. Von Deimling A, Louis DN, Von Ammon K, Petersen I, Höll T, Chung RY, Martuza RL, Schoenfeld DA, Yasargil MG, Wiestler OD and Seizinger BR (1992) Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme. J Neurosurg 77: 295-301
55. Watkins D, Dion F Poisson M, Delattre JY and Rouleau GA (1994) Analysis of oncogene expression in primary human gliomas: evidence for increased expression of the ros oncogene. Cancer Genet Cytogenet 72: 130-136
56. Whang-Peng J, Kao-Shan CS, Lee EC, Bunn PA, Carney DN, Gazdar AF and Minna JD (1982) Specific chromosome defect associated with human small-cell lung cancer: deletion 3p(14-23). Science 215: 181-182
57. Wick W, Petersen I, Schnitzler R, Wolfarth B, Lenartz D, Bierhoff E, Hümmerich J, Stangl AP, Schramm J, Wiestler OD and Von Deimling A (1996) Evidence for a novel tumour suppressor gene on chromosome 15 associated with progression to metastatic stage in breast cancer. Oncogene 12: 819-823
58. Wieland I and Bohm M (1994) Frequent allelic deletion at a novel locus on chromosome 5 in human lung cancer. Cancer Res 54: 1772-1774
59. Windle BE, Draper BW, Yin Y, O'Gorman S and Wahl GM (1991) A central role for chromosome breakage in gene amplification, deletion formation, and amplicon integration. Genes Dev 5: 160-174
60. Wodrich W and Volm M (1993) Overexpression of oncoproteins in non-small cell lung carcinomas of smokers. Carcinogenesis 14: 1121-1124
61. Wolf G, Petersen I, Roth K and Dietel M (1995) Computergestütztes Programm für die molekulare zytogenetische Analyse von soliden Tumoren mittels vergleichender genomischer Hybridisierung (CGH) und digitaler Bildverarbeitung. Verh Dtsch Ges Path 79: 1807
62. Wong AJ, Ruppert JM, Eggleston J, Hamilton SR, Baylin SB and Vogelstein B (1986) Gene amplification of c-myc and N-myc in small cell carcinoma of the lung. Science 233: 461-464
63. Yokota J, Wada M, Shimosato Y, Terada M and Sugimura T (1987) Loss of heterozygosity on chromosomes 3, 13 and 17 in small cell carcinoma and on chromosome 3 in adenocarcinoma of the lung. Proc Natl Acad Sci USA 84: 9252-9256
64. Yokota J, Tsukada Y, Nakajima T, Gotoh M, Shimosato Y, Mori N, Tsunokawa Y, Sugimura T and Terada M (1989) Loss of heterozygosity on the short arm of chromosome 3 in carcinoma of the uterine cervix. Cancer Res 49: 3598-3601